Zhan Zhang

1.1k total citations · 1 hit paper
21 papers, 863 citations indexed

About

Zhan Zhang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Zhan Zhang has authored 21 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Immunology. Recurrent topics in Zhan Zhang's work include Pregnancy and preeclampsia studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Birth, Development, and Health (2 papers). Zhan Zhang is often cited by papers focused on Pregnancy and preeclampsia studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Birth, Development, and Health (2 papers). Zhan Zhang collaborates with scholars based in China, United States and Australia. Zhan Zhang's co-authors include Zhenfeng Duan, Tianjian Lu, Yuqi Guo, Feng Xu, Ying Shi, Junjun Gao, Aimin Chang, Shujun Yan, Chenxi Huang and Francis J. Hornicek and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and International Journal of Cancer.

In The Last Decade

Zhan Zhang

20 papers receiving 851 citations

Hit Papers

Interleukin-6 signaling pathway in targeted therapy for c... 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhan Zhang China 12 370 331 190 149 81 21 863
Patricia Dauer United States 15 363 1.0× 512 1.5× 172 0.9× 262 1.8× 63 0.8× 21 1.0k
Ľ Danihel Slovakia 13 247 0.7× 432 1.3× 109 0.6× 253 1.7× 63 0.8× 67 952
Ashwini L. Chand Australia 22 566 1.5× 753 2.3× 329 1.7× 242 1.6× 69 0.9× 41 1.6k
Céline Van Themsche Canada 18 246 0.7× 544 1.6× 118 0.6× 228 1.5× 57 0.7× 25 894
Ying Luo China 16 125 0.3× 304 0.9× 122 0.6× 103 0.7× 103 1.3× 62 740
Janice García‐Quiroz Mexico 15 167 0.5× 313 0.9× 88 0.5× 114 0.8× 46 0.6× 40 687
Thomas Schöndorf Germany 21 341 0.9× 590 1.8× 209 1.1× 145 1.0× 215 2.7× 71 1.4k
Ece Konaç Türkiye 19 145 0.4× 468 1.4× 88 0.5× 280 1.9× 45 0.6× 59 941
Yu Song China 20 144 0.4× 535 1.6× 136 0.7× 328 2.2× 110 1.4× 58 1.2k
Gregory T. Wurz United States 17 277 0.7× 235 0.7× 106 0.6× 86 0.6× 94 1.2× 50 992

Countries citing papers authored by Zhan Zhang

Since Specialization
Citations

This map shows the geographic impact of Zhan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhan Zhang more than expected).

Fields of papers citing papers by Zhan Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhan Zhang. The network helps show where Zhan Zhang may publish in the future.

Co-authorship network of co-authors of Zhan Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhan Zhang. A scholar is included among the top collaborators of Zhan Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhan Zhang. Zhan Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chao, Guanglei Chen, Hao Wang, et al.. (2025). Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies. Signal Transduction and Targeted Therapy. 10(1). 97–97. 10 indexed citations
2.
Li, Nan, Yuying Fan, Zhan Zhang, et al.. (2025). WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma. Journal of Experimental & Clinical Cancer Research. 44(1). 201–201. 1 indexed citations
3.
Zhou, Qiang, Qiang Liu, Haojie Wang, et al.. (2024). DNA methylation inhibitors adverse reaction characteristic analysis: a descriptive analysis from WHO-VigiAccess. Frontiers in Pharmacology. 15. 1470148–1470148. 4 indexed citations
4.
Wang, Zihao, Zhan Zhang, Peishan Li, et al.. (2024). Multi-omics analysis reveals the genetic aging landscape of Parkinson’s disease. Scientific Reports. 14(1). 31167–31167. 2 indexed citations
6.
Y, Liu, Chang Lu, Linyuan Fan, et al.. (2023). PCGEM1 promotes cell proliferation and migration in endometriosis by targeting miR-124-3p-mediated ANTXR2 expression. BMC Women s Health. 23(1). 6 indexed citations
7.
Chen, Guanglei, Lisha Sun, Xi Gu, et al.. (2023). FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway. Science China Life Sciences. 66(12). 2805–2817. 11 indexed citations
9.
Mao, Ting, Zhan Zhang, Yizhou Zhao, et al.. (2021). Analysis of variation patterns in rice milled quality in the offspring of indica–japonica hybridization. Genetic Resources and Crop Evolution. 68(5). 1785–1797. 1 indexed citations
10.
Wang, Ping, Chenxi Huang, Junjun Gao, et al.. (2020). Resveratrol induces SIRT1-Dependent autophagy to prevent H2O2-Induced oxidative stress and apoptosis in HTR8/SVneo cells. Placenta. 91. 11–18. 38 indexed citations
11.
Liú, Wénwén, Zhan Zhang, Everard J. Edwards, et al.. (2020). Gene body demethylation increases expression and is associated with self-pruning during grape genome duplication. Horticulture Research. 7(1). 84–84. 14 indexed citations
12.
Zhang, Zhan, Chenxi Huang, Ping Wang, et al.. (2020). HIF‑1α affects trophoblastic apoptosis involved in the onset of preeclampsia by regulating FOXO3a under hypoxic conditions. Molecular Medicine Reports. 21(6). 2484–2492. 23 indexed citations
13.
Zhang, Zhan, Junjun Gao, Yang Feng, et al.. (2018). Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China. Scandinavian Journal of Clinical and Laboratory Investigation. 78(3). 211–218. 13 indexed citations
14.
Zhang, Zhan, Xinhui Wang, Ryo Hayashi, et al.. (2016). Targeting cancer stem cells with p53 modulators. Oncotarget. 7(29). 45079–45093. 17 indexed citations
15.
Yang, Xiaoqian, Yong Feng, Yan Gao, et al.. (2015). NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo. Gynecologic Oncology. 137(1). 134–142. 10 indexed citations
16.
Yang, Xiaoqian, Jacson Shen, Yan Gao, et al.. (2015). Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P‐glycoprotein and enhancing apoptosis. International Journal of Cancer. 137(8). 2029–2039. 23 indexed citations
17.
Chang, Aimin, Zhan Zhang, Liting Jia, et al.. (2013). Alteration of heat shock protein 70 expression levels in term and preterm delivery. The Journal of Maternal-Fetal & Neonatal Medicine. 26(16). 1581–1585. 15 indexed citations
18.
Guo, Yuqi, Feng Xu, Tianjian Lu, Zhenfeng Duan, & Zhan Zhang. (2012). Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treatment Reviews. 38(7). 904–910. 574 indexed citations breakdown →
19.
Duan, Zhenfeng, Xin Li, Haoxi Huang, et al.. (2012). Synthesis and Evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) Isomers To Reverse Multidrug Resistance in Cancer. Journal of Medicinal Chemistry. 55(7). 3113–3121. 38 indexed citations
20.
Zhang, Zhan, Lei Hou, Ping Xiong, et al.. (2005). Analysis of TAP1 and TAP2 polymorphism of mother-infant in Chinese patients with pre-eclampsia.. PubMed. 2(2). 141–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026